Sam Chun Dang Pharm. stock price

삼천당제약KRX:000250 · KOSDAQ · Healthcare
₩207,500+4.06%
2026-10-02 close
Loading chart…

Today's signals · Bollinger breakout

Signal details →

Sam Chun Dang Pharm. last closed at ₩207,500 (+4.06%) on 2026-10-02. Signals today: Bollinger breakout. Listed on KOSDAQ. Trailing 12 months PER is 272.5×. Its overall grade ranks 152 of 306 stocks in Healthcare.

About this company

Sam Chun Dang Pharm. last closed at ₩207,500 (+4.06%) on 2026-10-02. Signals today: Bollinger breakout. Listed on KOSDAQ.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall B · 152/306

Valuation grade F

Details →

Dividends

2025 dividend per share · ₩200 · Yield 0.00%

Details →

Recent filings

DART · received recent list, not a complete filing history. Factual information, not investment advice.

Details →

Related stocks

  • 알테오젠Competitor

    바이오의약품 기술이전·플랫폼 사업에서 국내 대표 경쟁사

  • 셀트리온Competitor

    바이오시밀러 중심의 국내 대형 경쟁사

  • 바이오의약품 위탁생산·바이오 사업 전반의 대형 경쟁사

Details →

ETFs holding this stock

TIGER 코스닥150바이오테크 · RISE 헬스케어 · TIGER 바이오TOP10

Details →
About Sam Chun Dang Pharm.
What technical signals does Sam Chun Dang Pharm. (000250) have?
Sam Chun Dang Pharm. current technical signals: Bollinger breakout.
Is Sam Chun Dang Pharm. a cup-and-handle pattern?
No. Sam Chun Dang Pharm. has no valid Cup signal right now.
What published figures are available for Sam Chun Dang Pharm.?
Market cap: KRW 4.9T. Trailing 12 months PER: 272.5×. Latest quarter PBR: 16.02×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-10-04 dataset

Disclosed suppliers

2026-06-04 dataset

Turn what you saw on this name into a strategy

Ask Q about Sam Chun Dang Pharm., or open the plan table on the main site.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Sam Chun Dang Pharm. notifications

Quantus Signal · live data · not investment advice · Privacy Policy